Emergent BioSolutions, Inc. (EBS)
8.14
+0.29
(+3.69%)
USD |
NYSE |
Apr 08, 10:04
Emergent BioSolutions EPS Diluted (Quarterly) : -1.042 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Boston Scientific Corp. | 0.4493 |
| Eli Lilly & Co. | 7.024 |
| Penumbra, Inc. | 1.202 |
| Disc Medicine, Inc. | -1.618 |
| MetaVia, Inc. | -0.8361 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -54.60M |
| Revenue (Quarterly) | 148.70M |
| Total Expenses (Quarterly) | 203.30M |
| Enterprise Value | 781.00M |
| Gross Profit Margin (Quarterly) | 31.34% |
| Profit Margin (Quarterly) | -36.72% |
| Earnings Yield | 10.51% |
| Operating Earnings Yield | 25.15% |
| Normalized Earnings Yield | 14.35 |